Patent 9523093 was granted and assigned to University of Iowa on December, 2016 by the United States Patent and Trademark Office.
The present invention is directed to RNA interference (RNAi) molecules targeted against a Huntington's disease nucleic acid sequence, and methods of using these RNAi molecules to treat Huntington's disease.